21.01.2015 Views

2013 Prior Authorization Drug Requirements - CCHP

2013 Prior Authorization Drug Requirements - CCHP

2013 Prior Authorization Drug Requirements - CCHP

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

FORMULARY<br />

DRUG<br />

BRAND NAME<br />

generic name<br />

VICTOZA INJ. 2<br />

VICTRELIS<br />

CAP 2<br />

DRUG<br />

TIER<br />

LEVEL<br />

COVERED<br />

USES<br />

patients<br />

started/stabiliz<br />

ed on<br />

intravenous<br />

(IV) or oral<br />

voriconazole<br />

for a systemic<br />

infection.<br />

All FDAapproved<br />

indications not<br />

otherwise<br />

excluded from<br />

<strong>CCHP</strong> Senior Select Program (HMO SNP)<br />

<strong>2013</strong> <strong>Prior</strong> <strong>Authorization</strong> <strong>Drug</strong> <strong>Requirements</strong><br />

Last Updated 04/01/<strong>2013</strong><br />

EXCLUSION<br />

CRITERIA<br />

REQUIRED<br />

MEDICAL<br />

INFORMATION<br />

AGE<br />

RESTRICTION<br />

Part D. N/A N/A N/A N/A<br />

All FDAapprovenanve<br />

HCV RNA titers.Tx-<br />

pts with chronic<br />

indications not<br />

HCV-1 monoinfection<br />

otherwise<br />

without cirrhosis and<br />

excluded from<br />

retx of pts with chronic<br />

Part D. Plus<br />

HCV-1 monoinfection<br />

adult patients<br />

who have been<br />

with Hepatitis<br />

previously treated with<br />

B virus<br />

interferon/peginterferon<br />

(HBV)/chroni<br />

alfa without<br />

c HCV<br />

cirrhosis,greater or equal<br />

genotype 1 co-N/A<br />

to 1 log10 reduction in Adults<br />

PRESCRIBER<br />

RESTRICTION<br />

All FDA-approved<br />

indications.<br />

Prescribed by or in<br />

consultation with a<br />

gastroenterologist<br />

or infectious<br />

disease physician.<br />

COVERAGE<br />

DURATION<br />

<strong>Authorization</strong><br />

will be for 12<br />

months, unless<br />

otherwise<br />

specified.<br />

FDA-approved<br />

indications,auth<br />

orization=8wks<br />

withTW 12, 24<br />

assessment.Othr<br />

=12mo.<br />

<strong>CCHP</strong> Senior Select Program (HMO SNP) is a Coordinated Care plan with a Medicare contract and a contract with the California Medicaid program.<br />

H0571_<strong>2013</strong>_142_FINAL_2 Approved 11282012<br />

233<br />

OTHER<br />

CRITERIA<br />

N/A<br />

HCV RNA titers<br />

not available but<br />

sent approve<br />

until available.<br />

For all FDAapproved<br />

indications,<br />

patient must<br />

have completed<br />

or will be<br />

completing a 4-<br />

week lead-in

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!